What is CGM?
Continuous Glucose Monitoring (CGM) is a technique that tracks glucose levels for the entire duration of the day. CGM technology records blood glucose readings and translates this information into meaningful data that reflects rate of change, average blood glucose, and other relevant information.
CGMs typically take the form of a wearable device that relays information to a companion smartphone app via Bluetooth, offering a user-friendly and minimally invasive method for monitoring blood glucose. These devices allow those with diabetes to better manage their sugar levels and make better decisions regarding lifestyle without needing repetitive finger stick tests.
CGM News
Release of Dexcom’s Newest CGM Delayed By COVID-19
Dexcom has recently acknowledged that the COVID-19 pandemic will likely delay the launch of the G7, their latest continuous glucose monitoring (CGM) sensor. “We remain confident in our ability to deliver G7, but acknowledge that the timing of the pivotal trial will be delayed due to the pausing of new trials at most clinical sites,” said Kevin Sayer, Dexcom CEO, in the company’s first-quarter earnings call.
Diabetes News
A Vaccine for Type 1 Diabetes? | CGM News Today
A team of researchers has recently created a vaccine for viruses that may contribute to the autoimmune issues leading to type 1 diabetes. This work, carried out by scientists at Karolinska Institutet in Sweden and at the universities of Jyväskylä and Tampere in Finland, could potentially provide protection against the chronic disease that troubles many.
Abstracts
Vitamin D Supplementation and Prevention of Type 2 Diabetes
Observational studies support an association between a low blood 25-hydroxyvitamin D level and the risk of type 2 diabetes. However, whether vitamin D supplementation lowers the risk of diabetes is unknown.
Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes
Diabetic ketoacidosis (DKA) is a serious acute complication of type 1 diabetes, which is receiving more attention given the increased DKA risk associated with SGLT inhibitors. Sociodemographic and modifiable risk factors were identified with strong evidence for an increased risk of DKA, including socioeconomic disadvantage, adolescent age (13-25 years), female sex, high HbA 1c, previous DKA, and psychiatric comorbidities (eg, eating disorders and depression).
Association Between Rotavirus Vaccination and Type 1 Diabetes in Children
Importance Because rotavirus infection is a hypothesized risk factor for type 1 diabetes, live attenuated rotavirus vaccination could increase or decrease the risk of type 1 diabetes in children. Objective To examine whether there is an association between rotavirus vaccination and incidence of type 1 diabetes in children aged 8 months to 11 years.